Nippon India Pharma Fund vs Kotak Healthcare Fund compare
Kotak Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High Risk | Very High Risk |
Asset Size (Cr) | ₹416 Cr | ₹8161 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 11 Dec 2023 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.39 | 1.82 |
Manager | Abhishek Bisen | Sailesh Raj Bhan |
ISIN Code | INF174KA1PW4 | INF204K01968 |
Exits Load | Kotak Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | -9.04% | -6% |
6 Month | -7.42% | -8.47% |
1 Year | 6.69% | 6.77% |
3 Year | - | 18.71% |
5 Year | - | 22.93% |
SIP Return Analysis
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | - | - |
1 Year | -0.42% | -1.87% |
3 Year | - | 21.17% |
5 Year | - | 19.06% |
Rolling Lumpsum Returns
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 31.01% | 18.19% |
3 Year | - | 20.5% |
5 Year | - | 20.36% |
Risk Management
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | - | 15.185% |
Sharp | - | 0.81% |
Beta | - | 0.931% |
Alpha | - | -0.33% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Abhishek Bisen | Sailesh Raj Bhan |
Total AUM | ₹0 Cr | ₹96086 Cr |
Fund Manage | 33 | 5 |
Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
Kotak Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 3.31 | 4.4 |
Small Cap | 24.27 | 22.52 |
Large Cap | 51.29 | 45.96 |
Mid Cap | 22.8 | 27.12 |
Sector Allocation
Scheme Name |
Kotak Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 3.31 | 4.4 |
Pharmaceuticals & Biotechnology | 79.49 | 75.86 |
Healthcare Services | 17.64 | 17.38 |
Insurance | 1.23 | - |
Retailing | - | 2.36 |
Top Comparisons
Kotak Medium Term Fund - Growth
3Y Returns6.15%
Nippon India Strategic Debt Fund - Growth Option
3Y Returns5.89%
BANDHAN Equity Savings Fund - Regular Plan - Growth
3Y Returns6.84%
Axis Equity Savings Fund - Regular Plan - Growth
3Y Returns8.11%
Kotak ELSS Tax Saver Fund-Scheme-Growth
3Y Returns13.63%
Canara Robeco ELSS Tax Saver Fund - Regular Plan - Growth Option
3Y Returns11.32%
Bajaj Finserv Flexi Cap Fund Regular - Growth
3Y Returns0%
HDFC Flexi Cap Fund - Growth Plan
3Y Returns21.78%